Additional hepatic Ho-radioembolization in patients with neuroendocrine tumours treated with Lu-DOTATATE : a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)

DSpace/Manakin Repository

 
 
See more statistics about this item